Schonfeld Strategic Advisors LLC Horizon Therapeutics Public LTD CO Transaction History

Schonfeld Strategic Advisors LLC

$14.6 Billion
Q2 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$98.98 - $115.74 $36.8 Million - $43 Million	371,452 Added 221.92%	538,836 $62.3 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $13.8 Million - $16.1 Million	142,842 Added 582.03%	167,384 $17.2 Million
Q1 2023 May 15, 2023	SELL	$107.32 - $113.5 $13.7 Million - $14.5 Million	-127,990 Reduced 83.91%	24,542 $2.68 Million
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $487,328 - $888,891	-7,811 Reduced 4.87%	152,532 $17.4 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $2.62 Million - $3.76 Million	44,422 Added 38.32%	160,343 $9.92 Million
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $4.6 Million - $6.74 Million	57,881 Added 99.73%	115,921 $9.25 Million
Q1 2022 May 16, 2022	BUY	$86.42 - $109.81 $3.18 Million - $4.05 Million	36,840 Added 173.77%	58,040 $6.11 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $4.72 Million - $5.74 Million	-47,909 Reduced 69.32%	21,200 $2.28 Million
Q3 2021 Nov 16, 2021	BUY	$91.91 - $110.37 $1.51 Million - $1.81 Million	16,392 Added 31.09%	69,109 $7.57 Million
Q2 2021 Nov 16, 2021	SELL	$86.24 - $95.92 $950,968 - $1.06 Million	-11,027 Reduced 17.3%	52,717 $4.94 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $1.91 Million - $2.13 Million	22,181 Added 53.37%	63,744 $5.97 Million
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $1.31 Million - $1.74 Million	18,263 Added 78.38%	41,563 $3.83 Million
Q4 2020 Feb 16, 2021	SELL	$67.0 - $84.39 $7.31 Million - $9.21 Million	-109,175 Reduced 82.41%	23,300 $1.7 Million
Q3 2020 Nov 16, 2020	BUY	$55.23 - $79.93 $4.84 Million - $7.01 Million	87,663 Added 195.62%	132,475 $10,000
Q2 2020 Aug 14, 2020	BUY	$30.2 - $56.98 $538,919 - $1.02 Million	17,845 Added 66.17%	44,812 $2.49 Million
Q1 2020 May 15, 2020	SELL	$24.87 - $38.56 $458,652 - $711,123	-18,442 Reduced 40.61%	26,967 $799,000
Q4 2019 Feb 14, 2020	SELL	$25.43 - $36.67 $4.74 Million - $6.84 Million	-186,573 Reduced 80.43%	45,409 $1.65 Million
Q3 2019 Nov 14, 2019	BUY	$23.0 - $27.97 $3.67 Million - $4.46 Million	159,443 Added 219.8%	231,982 $6.32 Million
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $1.65 Million - $2.07 Million	72,539 New	72,539 $1.75 Million

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.

Account